Active Ingredient(s):Hydroxyurea FDA Approved: * December 7, 1967 Pharm Company: *BRISTOL MYERS SQUIBB Category:HIV / AIDS
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, essential thrombocythemia, chronic myelogenous leukemia and cervical cancer.[1][2] In sickle-cell disease it increases fetal hemoglobin and decreases the number of attacks.[1] It is taken by mouth.[1]
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches....
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.